ACE-Hemmer in einem menschlichen Restenose-Modell
作者： G. R. Heyndrickx
DOI: 10.1007/978-3-662-11145-1_12
关键词:
摘要: Die perkutane transluminale Koronarangioplastie (PTCA) wurde 1977 von Andreas Gruentzig als Alternativbehandlung zur Koronararterienbypasstransplantation (coronary artery bypass grafting, CABG) eingefuhrt, um die Koronardurchblutung bei Patienten mit einer obstruktiven Koronararterienerkrankung wiederherzustellen (15). Durch zunehmende Erfahrung und technische Fortschritte kam es zu hoheren primaren Erfolgsrate (uber 90%) niedrigen Komplikationsrate (Tod, nicht-letaler Herzinfarkt; 4–5%) (9). Rate spat auftretender Restenosen (17% bis 40%) limitiert jedoch den gunstigen Langzeiteffekt der Masnahme immer noch (21, 23, 47, 52).
springer.com
sci-hub.st 参考文章(47)
A Hammacher, U Hellman, A Johnsson, A Ostman, K Gunnarsson, B Westermark, A Wasteson, C H Heldin, A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain Journal of Biological Chemistry. ,vol. 263, pp. 16493- 16498 ,(1988) , 10.1016/S0021-9258(18)37619-1
Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group. Circulation. ,vol. 86, pp. 100- 110 ,(1992) , 10.1161/01.CIR.86.1.100
P W Serruys, W Rutsch, G R Heyndrickx, N Danchin, E G Mast, W Wijns, B J Rensing, J Vos, J Stibbe, Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT). Circulation. ,vol. 84, pp. 1568- 1580 ,(1991) , 10.1161/01.CIR.84.4.1568
G Dorros, M J Cowley, J Simpson, L G Bentivoglio, P C Block, M Bourassa, K Detre, A J Gosselin, A R Grüntzig, S F Kelsey, K M Kent, M B Mock, S M Mullin, R K Myler, E R Passamani, S H Stertzer, D O Williams, Percutaneous transluminal coronary angioplasty: report of complications from the National Heart, Lung, and Blood Institute PTCA Registry. Circulation. ,vol. 67, pp. 723- 730 ,(1983) , 10.1161/01.CIR.67.4.723
Richard M. Fleming, Richard L. Kirkeeide, Richard W. Smalling, K.Lance Gould, Yvonne Stuart, Patterns in visual interpretation of coronary arteriograms as detected by quantitative coronary arteriography. Journal of the American College of Cardiology. ,vol. 18, pp. 945- 951 ,(1991) , 10.1016/0735-1097(91)90752-U
Jerry S. Powell, Rita K. M. Müller, Marianne Rouge, Herbert Kuhn, Fridolin Hefti, Hans R. Baumgartner, The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. Journal of Cardiovascular Pharmacology. ,vol. 16, ,(1990) , 10.1097/00005344-199016004-00010
Andreas R. Grüntzig, Åke Senning, Walter E. Siegenthaler, Nonoperative Dilatation of Coronary-Artery Stenosis New England Journal of Medicine. ,vol. 301, pp. 61- 68 ,(1979) , 10.1056/NEJM197907123010201
A J Naftilan, R E Pratt, V J Dzau, Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. Journal of Clinical Investigation. ,vol. 83, pp. 1419- 1424 ,(1989) , 10.1172/JCI114032
S. R. Hanson, J. S. Powell, T. Dodson, A. Lumsden, A. B. Kelly, J. S. Anderson, A. W. Clowes, L. A. Harker, Effects of angiotensin converting enzyme inhibition with cilazapril on intimal hyperplasia in injured arteries and vascular grafts in the baboon. Hypertension. ,vol. 18, ,(1991) , 10.1161/01.HYP.18.4_SUPPL.II70
M W Majesky, M A Reidy, D F Bowen-Pope, C E Hart, J N Wilcox, S M Schwartz, PDGF ligand and receptor gene expression during repair of arterial injury. Journal of Cell Biology. ,vol. 111, pp. 2149- 2158 ,(1990) , 10.1083/JCB.111.5.2149